Details of Host Immune Factor (HIF) Regulating Microbe Species (MIC)
General Information of HIF (ID: HIFM0023) | |||||
---|---|---|---|---|---|
HIF Name |
C-C motif chemokine 20
|
||||
HIF Synonym(s) |
C-C motif chemokine ligand 20, CKb4, Exodus, LARC, MIP-3-alpha, MIP-3a, MIP3A, SCYA20, ST38
|
||||
HIF Classification |
Cytokine (Cyt)
|
||||
Molecular Function |
Antibiotic; Antimicrobial; Cytokine
|
||||
Description | Chemokines were originally described as cytokines that mediate leukocyte recruitment to sites of inflammation | [1] | |||
Pfam | Small cytokines (intecrine/chemokine), interleukin-8 like (PF00048 ) | ||||
Pathway | Chemokine signaling pathway (hsa04062 ) | ||||
Cytokine-cytokine receptor interaction (hsa04060 ) | |||||
IL-17 signaling pathway (hsa04657 ) | |||||
Rheumatoid arthritis (hsa05323 ) | |||||
TNF signaling pathway (hsa04668 ) | |||||
Viral protein interaction with cytokine and cytokine receptor (hsa04061 ) | |||||
Sequence | Click here to download the HIF sequence in FASTA format | ||||
External Links | |||||
Uniprot ID | |||||
Microbe Species (MIC) Regulated by This HIF | |||||
---|---|---|---|---|---|
Bifidobacterium longum subsp. infantis (actinobacteria) | MIC00215 | ||||
Description | Bifidobacterium infantis could-dependently inhibited the secretion of CCL20 by IECs. | [2] | |||
Candida albicans (budding yeasts) | MIC00317 | ||||
Description | CCL20 has a property conferring a direct antimicrobial enzymatic activity against Candida albicans. | [2] | |||
Clostridioides difficile (firmicutes) | MIC00396 | ||||
Description | The CCL20 secretion by IECs after infection by Clostridium difficile was shown to be negatively modulated by preincubation with commensal bacteria. | [2] | |||
Escherichia coli (enterobacteria) | MIC00516 | ||||
Description | CCL20 has a property conferring a direct antimicrobial enzymatic activity against Escherichia coli. | [2] | |||
Listeria monocytogenes (firmicutes) | MIC00771 | ||||
Description | During intestinal infection by Listeria monocytogenes, the production of CCL20 was increased. | [2] | |||
Mycobacterium tuberculosis (actinobacteria) | MIC00857 | ||||
Description | There is no difference in global expression of the production of the CCL20 protein in the lungs after Mycobacterium tuberculosis infection. | [3] | |||
Prevotella bivia (CFB bacteria) | MIC01007 | ||||
Description | Prevotella bivia could induce higher level expression of CCL20. | [4] | |||
Prevotella nanceiensis (CFB bacteria) | MIC01018 | ||||
Description | Prevotella nanceiensis can increased levels of CCL20 expression to induce severe lung neutrophilia in mice. | [4] | |||
Salmonella enterica subsp. enterica (enterobacteria) | MIC01154 | ||||
Description | The CCL20 secretion by IECs after infection by Salmonella typhimurium was shown to be negatively modulated by preincubation with commensal bacteria. | [2] | |||
Shigella flexneri (enterobacteria) | MIC01182 | ||||
Description | Shigella flexneri is able to downregulate the CCL20 response. | [2] | |||
Staphylococcus aureus (firmicutes) | MIC01208 | ||||
Description | CCL20 has a property conferring a direct antimicrobial enzymatic activity against Staphylococcus aureus. | [2] | |||
Yersinia enterocolitica (enterobacteria) | MIC01398 | ||||
Description | The CCL20 expresssion has been observed during infection by Yersinia enterocolitica. | [2] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.